IART Operating Cash Flow (Statement)
Integra Lifesciences Holdings Corp · Operating Cash Flow (Statement)
IART Operating Cash Flow (Statement)
Latest reported$85.33Mperiod ending
IART TTM Cash from Operations (-$8.00M → $85.33M)
TTM operating cash flow (statement)
High-resolution chart · PNG
IART operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 3,117,000 | |
| 850,000 | |
| -4,960,000 | |
| -1,997,000 | |
| -4,193,000 | |
| 3,940,000 | |
| 2,500,000 | |
| -2,000,000 | |
| -3,500,000 | |
| -10,400,000 | |
| -9,800,000 | |
| -10,900,000 | |
| -10,300,000 | |
| -8,800,000 | |
| -7,900,000 | |
| -5,900,000 | |
| -5,800,000 | |
| -7,100,000 | |
| -8,000,000 | |
| -7,100,000 |